These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12242999)

  • 1. [Effects of topiramate in patients with epilepsy and intellectual deficits].
    Huber B
    Nervenarzt; 2002 Jun; 73(6):525-32. PubMed ID: 12242999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of adjunctive topiramate therapy on seizure severity and health-related quality of life in patients with refractory epilepsy---a Canadian study.
    Baker GA; Currie NG; Light MJ; Schneiderman JH;
    Seizure; 2002 Jan; 11(1):6-15. PubMed ID: 11888254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topiramate in patients with learning disability and refractory epilepsy.
    Kelly K; Stephen LJ; Sills GJ; Brodie MJ
    Epilepsia; 2002 Apr; 43(4):399-402. PubMed ID: 11952770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cognitive impairments due to add-on therapy with topiramate].
    Huppertz HJ; Quiske A; Schulze-Bonhage A
    Nervenarzt; 2001 Apr; 72(4):275-80. PubMed ID: 11320862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of topiramate in adults with intractable epilepsy, mental retardation, and developmental disabilities.
    Singh BK; White-Scott S
    Seizure; 2002 Jan; 11(1):47-50. PubMed ID: 11888260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topiramate slow dose titration: improved efficacy and tolerability.
    Albsoul-Younes AM; Salem HA; Ajlouni SF; Al-Safi SA
    Pediatr Neurol; 2004 Nov; 31(5):349-52. PubMed ID: 15519117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages. Topiramate YE Study Group.
    Privitera M; Fincham R; Penry J; Reife R; Kramer L; Pledger G; Karim R
    Neurology; 1996 Jun; 46(6):1678-83. PubMed ID: 8649569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Add-on topiramate in the treatment of refractory partial-onset epilepsy: clinical experience of outpatient epilepsy clinics from 11 general hospitals.
    Giannakodimos ST; Georgiadis G; Tsounis ST; Triantafillou N; Kimiskidis V; Giatas K; Karlovasitou A; Mitsikostas DD; Thodi E; Polychronopoulos P; Ramopoulos N; Michailidis K; Michalis N; Garganis K; Gatzonis ST; Balogiannis ST; Kazis AR; Milonas J; Van Oene JC
    Seizure; 2005 Sep; 14(6):396-402. PubMed ID: 16019237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topiramate: a new antiepileptic drug for refractory epilepsy.
    Walker MC; Sander JW
    Seizure; 1996 Sep; 5(3):199-203. PubMed ID: 8902921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topiramate in the treatment of severe myoclonic epilepsy in infancy.
    Nieto-Barrera M; Candau R; Nieto-Jimenez M; Correa A; del Portal LR
    Seizure; 2000 Dec; 9(8):590-4. PubMed ID: 11162758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, double-blind, placebo-controlled trial of topiramate in adults with epilepsy and intellectual disability: impact on seizures, severity, and quality of life.
    Kerr MP; Baker GA; Brodie MJ
    Epilepsy Behav; 2005 Nov; 7(3):472-80. PubMed ID: 16140593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topiramate titration to response: analysis of individualized therapy study (TRAITS).
    Dodson WE; Kamin M; Kraut L; Olson WH; Wu SC
    Ann Pharmacother; 2003 May; 37(5):615-20. PubMed ID: 12708932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of topiramate in refractory epilepsy of childhood: long-term follow-up study.
    Grosso S; Franzoni E; Iannetti P; Incorpora G; Cardinali C; Toldo I; Verrotti A; Caterina Moscano F; Lo Faro V; Mazzone L; Zamponi N; Boniver C; Spalice A; Parisi P; Morgese G; Balestri P
    J Child Neurol; 2005 Nov; 20(11):893-7. PubMed ID: 16417859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pooled analysis of adjunctive topiramate in refractory partial epilepsy.
    Peeters K; Adriaenssen I; Wapenaar R; Neto W; Pledger G
    Acta Neurol Scand; 2003 Jul; 108(1):9-15. PubMed ID: 12807387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topiramate in add-on therapy: results from an open-label, observational study.
    Krakow K; Lengler U; Rettig K; Schreiner A; Schauble B;
    Seizure; 2007 Oct; 16(7):593-600. PubMed ID: 17543544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring efficacy and tolerability outcomes in patients with difficult-to-treat epilepsy receiving adjunctive topiramate at different titration rates--an exploratory study.
    Kurth C; Schäuble B; Schreiner A; Rettig K; Steinhoff BJ
    Acta Neurol Scand; 2009 Aug; 120(2):80-7. PubMed ID: 19432934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized dose-controlled study of topiramate as first-line therapy in epilepsy.
    Arroyo S; Dodson WE; Privitera MD; Glauser TA; Naritoku DK; Dlugos DJ; Wang S; Schwabe SK; Twyman RE;
    Acta Neurol Scand; 2005 Oct; 112(4):214-22. PubMed ID: 16146489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experience with topiramate dosing and serum levels in patients with epilepsy.
    Zanotta N; Raggi ME; Radice L; Degrate A; Bresolin N; Zucca C
    Seizure; 2006 Mar; 15(2):86-92. PubMed ID: 16406695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience with open-label topiramate use in infants younger than 2 years of age.
    Watemberg N; Goldberg-Stern H; Ben-Zeev B; Berger I; Straussberg R; Kivity S; Kramer U; Brand N; Lerman-Sagie T
    J Child Neurol; 2003 Apr; 18(4):258-62. PubMed ID: 12760428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical experiences with topiramate in children with intractable epilepsy.
    Uldall P; Buchholt JM
    Eur J Paediatr Neurol; 1999; 3(3):105-11. PubMed ID: 10461565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.